The Prognostic Model Established by the Differential Expression Genes Based on CD8⁺ T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma

Figure 4

Evaluation of risk models for CD8-DEGs. (a) OS patients were divided into high- and low-risk groups according to the optimal cutoff (2.97) value. (b, c) Comparison of OS between high- and low-risk scores in the training and validation cohorts. (d) Univariate analysis of CD8-DEG risk scores and clinical characteristics. (e, f) Comparison of the predictive power of CD8-DEG risk models and their clinical characteristics.

(a)

(b)

(c)

(d)

(e)

(f)